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Aim: The dysregulation of regulatory element-binding protein-1c (SREBP-1c) is associated with hepatic
steatosis. However, effects of exercise on SREBP-1c protein level in liver have not been investigated. Thus,
in this study we investigated if reversion of the hepatic steatosis-induced by exercise training is related
with levels of SREBP-1c.
Main methods:Mice were divided into two groups: control lean mice (CT), fed on standard rodent chow, and
obese mice (HF), fed on a high-fat diet for 2 months. After this period obese mice were divided in two
groups: obese mice and obese mice submitted to exercise (HF+EXE). The HF+EXE group performed a run-
ning program of 50 min per day, 5 days per week, for 8 weeks. Forty-eight hours after the last exercise ses-
sion, biochemical, immunoblotting, histology and immunohistochemistry analyses were performed.
Key ﬁndings: Livers of HF mice showed increased SREBP-1c, FAS (Fatty Acid Synthase), SCD1 (Stearoyl-CoA
Desaturase1) and CPT1 (Carnitine Palmitoyl Transferase1) protein levels (3.4, 5.0, 2.6 and 2.9 times, respec-
tively), though ACC (Acetyl-CoA Carboxilase) phosphorylation dropped 4.2 times. In livers of HF+EXE, levels
of SREBP-1c, FAS, SCDI and CPTI decreased 2.1, 1.9, 1.8, and 2.7 times, respectively), while ACC phosphoryla-
tion increased 3.0 times. Lower SREBP-1c protein levels after exercise were conﬁrmed also by immunohisto-
chemistry. Total liver lipids content was higher in HF (2.2 times) when compared to CT, and exercise training
reduced it signiﬁcantly (1.7 times).
Signiﬁcance: Our study allows concluding that the reduction in SREBP-1c protein levels is associated with
steatosis reversion induced by exercise training.Crown Copyright © 2012 Published by Elsevier Inc. All rights reserved.Introduction
The liver plays a central role in whole body lipidmetabolism. There-
fore, this regulation affects whole-body lipid composition andmay con-
tribute to the onset and progression of several chronic diseases,
including atherosclerosis, diabetes, and obesity (for a review see
Jump, 2011). Since dysregulations in hepatic lipid synthesis have been
associated with several diseases, a comprehensive understanding of li-
pogenesis regulation seems crucial in both physiology and physiopa-
thology studies.
The mechanism of triacylglycerol synthesis in liver has been in-
tensely studied. In line with that, the sterol regulatory element bind-
ing proteins (SREBPs), which are master transcription factors whichia e Bioquímica do Exercício,
Universidade do Extremo Sul
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12 Published by Elsevier Inc. All righregulate lipid metabolism, was discovered (Wang et al., 1993). The
SREBP family has been established as a group of transcription factors
regulating transcription of genes involved in cholesterol and fatty
acid synthesis. These proteins are inserted into the endoplasmic re-
ticulum (ER)membrane with both the amino and carboxylic acid do-
mains facing the cytosolic side of the membrane. In sterol deﬁcient
cells, proteolytic cleavage of SREBPs (125 kDa) occurs, which
makes them release their N-terminal mature and active forms
(68 kDa) and enabling them to enter the nucleus, where they bind
to the sterol regulatory response element (SRE) and/or E-box sequences
and activate genes involved in cholesterol, triglyceride, and fatty acid bio-
synthesis (Brown and Goldstein, 1997; Nohturfft et al., 2000; Nohturfft et
al., 1999). A number of studies have reported that SREBP-1c levels are
high in alcoholic or non-alcoholic fatty liver disease (for a review see
Ahmed and Byrne, 2007; Yang et al., 2010; You and Crabb, 2004), and
fatty liver was attenuated in mice deﬁcient in SREBP-1 (Yahagi et al.,
2002). Furthermore, SREBP-1c plays a pivotal role in the dietary regula-
tion of most hepatic lipogenic genes, like fatty acid synthase (FAS),ts reserved.
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(Brown and Goldstein, 1997; Nohturfft et al., 2000, 1999).
The ACC catalyzes the carboxylation of acetyl-CoA to form
malonyl-CoA, which is a key molecule in the control of intracellular
fatty acid metabolism (Abu-Elheiga et al., 1995; Ruderman et al.,
1999). Results suggest that ACC is involved in regulating fat oxidation
in the liver and that the use of antisense oligonucleotide (anti-ACC)
technique reverses hepatic steatosis in high-fat fed rats (Savage et al.,
2006). ACC is a major isozyme that supplies malonyl-CoA to FAS, the
multifunctional enzyme catalyzing the de novo synthesis of fatty acid
in many tissues via subsequent nutritional and hormonal regulation
(Abu-Elheiga et al., 1995; Ruderman et al., 1999). SREBP-1c also plays
pivotal regulation of SCD1. SCD1 is a central lipogenic enzyme that cat-
alyzes the delta 9-cis desaturation of saturated fatty acyl-CoA used in
the biosynthesis of monounsaturated fatty acids (MUFAs). Recent stud-
ies with a mouse model with SCD1 targeted disruption gene have pro-
vided evidence that SCD1 plays an important role in lipid homeostasis
and lipoprotein metabolism (Cohen et al., 2002; Miyazaki et al., 2000,
2007).
According to what is presented above, the liver plays a crucial role
in fat metabolism. In addition, physical exercise has been demonstrat-
ed to increase metabolism in general, especially fat liver metabolism
(Johnson et al., 2009; Schultz et al., 2012; Yasari et al., 2010). Physical
exercise, one of most extreme metabolic forms of stress experienced,
leads to activation/inactivation of the many enzymes in the liver that
are associated as fatty acid oxidation and triglyceride formation
(Johnson et al., 2009; Marques et al., 2010; Rector et al., 2008a;
Schultz et al., 2012; Yasari et al., 2010). On the other hand, low aero-
bic ﬁtness, by itself or combined with overnutrition, is the underlying
cause of NAFLD (for a review see Rector et al., 2011), and cessation of
physical activity alters fat oxidation capacity in the liver (Rector et al.,
2008b). The reversion of fatty liver induced by exercise has been
poorly investigated. In an elegant work on the subject, Rector et al.
(2008a) indicated that exercise has a beneﬁc effect upon hepatic
lipid metabolism. That said, the next step is the identiﬁcation of the
molecular mechanisms responsible for these exercise-induced alter-
ations. In addition, effects of exercise on SREBP-1c transcriptional fac-
tor in liver have not been investigated. In this scenario, this study
investigates the involvement of SREBP-1c in decreasing hepatic lipid
content after exercise training.
Material and methods
Animals and diet
Four-week-old male Swiss mice were obtained from our breeding
colony (UNESC) and kept housed in individual cages under a 12-h
artiﬁcial light–dark cycle. The investigation followed the University
guidelines for the use of animals in experimental studies. After the
acclimatization period (3 days), the animals were randomly divided
into two groups: lean control mice (CT), fed on standard rodent
chow, and obese mice, fed on a high-fat diet for 2 months, character-
izing diet-induced obesity (HF). Eight weeks of fat-rich diet feeding
were deﬁned as the time by which all mice should have developed
obesity (De Souza et al., 2005). After this period, obese mice were
divided in two groups: mice fed on high-fat diet and non-trained
(HF) and mice fed on high-fat diet and submitted to exercise training
(HF+EXE).
Exercise protocol and proceeding
The group of mice trained was habituated on a nine-channel
motor-drive treadmill at a speed of 10 m/min for 10 min/day for one
week, to reduce stress to the new environment. The mice did not re-
ceive any electric stimulus to run, but manual stimulation was used.
The exercise group performed a running program of 50 min per day(1.0 km/h), 5 days per week, for 8 weeks (Fernando et al., 1993). The
non-trained mice were placed on the switched-off treadmill for the
same 8 weeks. Forty-eight hours after the last exercise session, one
set ofmice (n=8)was randomly chosen and anesthetized for hormone
and biochemical analysis. Another set of mice was decapitated for
immunoblotting and total hepatic lipids (n=6) and histology and
immunohistochemistry (n=6). The mice used for hormone and bio-
chemical analysis were anesthetized with an intraperitoneal (i.p) in-
jection of ketamine chlorohydrate (50 mg/kg; Ketalar; Parke-Davis,
Ann Arbor, MI) and xylazine (20 mg/kg; Rompun; Bayer, Leverkusen),
and decapitated.
Hormone and biochemical measurements
After a 6-h fasting period, serum insulin was determined using a
commercially available Enzyme Linked Immunosorbent Assay (ELISA)
kit (Crystal Chem Inc., Chicago, IL), and blood glucose was measured
by glucosimeter (Advantage, Boehringer Mannheim, Irvine, CA). Total
liver fat was extracted. For this, 4.0 mL chloroform/methanol 2:1 (v/v)
was added to each 1 g of liver sample, vortexed well and incubated at
room temperature for 5 min. Then, additional volumes of 1.25 mL
chloroform and 1.25 mL deionized H2Owere added, and ﬁnally, follow-
ing vigorous homogenized for 3 min, samples were centrifuged at
1000 rpm for 5 min at room temperature to obtain a two-phase sys-
tem: aqueous top and organic bottom phases from which lipids were
obtained.
Protein analysis by immunoblotting
Forty-eight hours after the last session of the exercise protocol mice
were decapitated and liver fragments were homogenized in extraction
buffer (1% Triton-X 100, 100 mM Tris, pH 7.4, containing 100 mM
sodium pyrophosphate, 100 mM sodium ﬂuoride, 10 mM EDTA,
10 mM sodium vanadate, 2 mM PMSF and 0.1 mg of aprotinin/ml) at
4 °C with a Polytron MR 2100 (Kinematica, Switzerland). The extracts
were centrifuged at 11,000 rpm and 4 °C in an Eppendorf centrifuge
5804R (Eppendorf AG, Hamburg, Germany) for 40 min to remove insol-
uble material. The supernatants of these tissues were used for protein
quantiﬁcation (Bradford, 1976) and proteins were denaturated by boil-
ing in Laemmli (Laemmli, 1970) sample buffer containing 100 mMDTT.
After, 0.2 mg of protein extracts obtained from each sample were sepa-
rated by SDS-PAGE, transferred to nitrocellulose membranes and blot-
ted with anti-ACC, anti-CPT1, anti-FAS, anti-SREBP-1c, anti-SCD1, and
anti-β-actin purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA); and anti-phospho [Ser79]ACC purchased from Cell Signaling
Technology (Beverly, MA, USA). The original membrane was stripped
and reblotted with β-actin loading protein. Chemiluminescent detec-
tion was performed with horseradish peroxidase-conjugate secondary
antibodies. Autoradiographs ofmembraneswere taken for visualization
of protein bands. The results of blots are presented as direct compari-
sons of bands in autoradiographs and quantiﬁed by densitometry
using the Scion Image software.
Histology
Hydrated, 5.0-μm sections of paraformaldehyde-ﬁxed, parafﬁn-
embedded liver fragments of four mice were stained with
haematoxylin/eosin and photo-documented using an Olympus
BX60 microscope.
Immunohistochemistry
Livers obtained from four mice were examined to determine the
expression and tissue distribution of SREBP-1c protein, as previously
described (Araujo et al., 2004). Hydrated, 5.0-μm sections of
paraformaldehyde-ﬁxed, parafﬁn-embedded tissue were transferred
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twice in 0.01 M phosphate-buffered saline (PBS), pH 7.4 and incubat-
ed in PBS with 1% bovine serum albumin (BSA, w/v) for 30 min to
block nonspeciﬁc background. Upon BSA removal, the sections were
treated with primary antibody anti SREBP-1c (Santa Cruz Biotechnol-
ogy, Inc., Santa Cruz, CA) at a 1:100 dilution in PBS/BSA overnight at
4 °C. After washing in PBS, slides were covered with a 1:200 dilution
of FITC-conjugated donkey anti-rabbit IgG secondary antibody (Santa
Cruz Biotechnology Inc., Santa Cruz, CA) in PBS, for 120 min. The sec-
tions were subsequently washed in PBS and incubated for 10 min
with DAPI (Vectashield, Vector Laboratory Inc., USA) prepared
according to manufacturer's instructions. Photo-documentation of re-
sults was performed using a Leica FW 4500 B microscope. Represent
the positive SREBP-1c cells number quantiﬁcation of HF and HF+EXE
groups were performed.
Statistical analysis
The results were expressed as the means±SEM. Differences be-
tween the groups were evaluated using one-way analysis of variance
(ANOVA) followed by the Bonferroni post‐hoc test. A probability of
less than 0.05 was considered signiﬁcant. The software used for anal-
ysis of the data was the Statistical Package for the Social Sciences
(SPSS) version 17.0 for Windows.
Results
Physiological and metabolic parameters
Table 1 shows comparative data for the CT, HF and HF+EXE
groups. The HF mice were heavier, presented higher levels of epidid-
ymal fat, fasting serum insulin, and fasting glucose than age matched
controls. Signiﬁcant variations were found in body weight, epididy-
mal fat, serum insulin and blood glucose of HF mice after exercise
training, when compared to HF non-trained group. No difference
was observed in food intake in the three groups (data not shown).
Exercise training reduces SREBP-1c, FAS and SCD1 protein levels in liver
of HF mice
The effects of exercise training on transcription factor SREBP-1c
and the protein levels of the enzymes (FAS and SCD1) controlled by
it were examined in livers of CT, HF and HF+EXE. SREBP-1c levels
increased 3.4 times in livers of HF mice, when compared to CT
group (Fig. 1A). In HF+EXE, SREBP-1c was reduced by 2.1 times,
when compared with the HF group (Fig. 1A). High-fat diet induced
an increase in FAS protein levels. In the livers from HF mice, FAS pro-
tein levels increased 5.0 times, when compared with CT (Fig. 1B). In the
liver of HF+EXE mice, FAS dropped by a factor of 1.9, when compared
with the HF group. The high-fat diet increased SCD1 protein levels by
2.6 times, and exercise led to a 1.8-fold drop in the parameter
(Fig. 1C). As SREBP-1c antibody recognizes the membrane-bound and
nuclear forms, we performed long-run SDS-PAGEs with 0.2 mg protein
samples. As illustrated in Fig. 1A, the ~125 kDa (membrane-bound
form) and ~68 kDa (nuclear form) bands detected in total liver protein
extract indicates, respectively, were the precursor and mature forms ofTable 1
Physiological and metabolic parameters.
Groups
(n=8)
Body weight (g) Epididymal fat (g/%) Insulin
(ng/mL−1)
Blood glucose
(mg/dL−1)
CT (lean) 37.5±1.22 2.9±0.29 2.8±0.69 108.3±4.14
HF 53.9±1.11# 5.1±0.83# 14.7±2.64# 255.5±18.17#
HF+EXE 45.6±1.01* 3.7±0.52* 9.2±2.02* 142.5±16.26*
#pb0.05, HF mice at rest versus CT group, and *pb0.05, HF+EXE mice versus HF
group at rest. Results are expressed as mean±SEM.SREBP-1c protein. The levels of precursor aswell as themature forms of
SREBP-1c were higher when the mice were submitted to high-fat diet
(Fig. 1A – long-run SDS-PAGE). On the other hand, the protein levels
of the two forms of SREBP-1c were reduced after exercise protocol in
these obese mice (Fig. 1A – long-run SDS-PAGE). The membrane was
stripped and immunoblotted with anti-β-actin as loading protein. Nei-
ther treatment changed β-actin protein levels.
Exercise training increases ACC phosphorylation and CPT1 protein levels
in liver of HF mice
The high-fat diet reduces the phosphorylation of ACC (4.2 times),
when compared to the CT group (Fig. 2A). Exercise training increases
ACC phosphorylation by a factor of 3.0, when compared to the HF
group (Fig. 2A). CPT1 protein levels decreased 2.9 times in livers of HF
mice, when comparedwith the CT group (Fig. 2B). The exercise training
adopted here increased the level of CPT1 by 2.7 times, when compared
to the HF group, demonstrating a similar alteration in ACC phosphoryla-
tion. Exercise did not lead to any difference in ACC total protein levels
(Fig. 2A – lower panel). Fig. 2B, lower panel, shows the membrane
stripped and immunoblotted with anti-β-actin as loading protein.
Exercise training reduces total hepatic lipids in HF mice
Total lipid extraction and histological analysis was performed.
Fig. 3B shows lipid deposition in liver slices. The CT group showed
clear and conserved parenchyma. Fat drops in hepatocyte of the HF
group were larger, characterizing a steatotic hepatic state, with consid-
ering fat depots predominant in the perivenular zone and spreading to
the external areas of the lobule. On the other hand, exercise training
markedly reduces it. Similarly, total liver lipid contentwas higher in an-
imals of the HF group (2.2 times) than in animals of CT (Fig. 3A). On the
other hand, exercise training reduced (1.7 times) signiﬁcantly the total
liver lipids content.
SREBP-1c levels were also evaluated by immunoﬂuorescence
staining. Comparative evaluation of the pattern of staining suggested
that livers of obese mice submitted to exercise training expressed
lower levels of SREBP-1c, when compared with HF group (Fig. 4A). Im-
munohistochemistry quantiﬁcation showed a percentage change in
SREBP-1c positive cells number of HF+EXE 50% lower compared with
HF group (Fig. 4B). The results are in accordance with those observed
in Fig. 1A.
Discussion
Hepatic steatosis is a secondary, but not less important, characteris-
tic of cardiometabolic risk. Effective changes in lifestyle emerge as im-
portant strategies to reduce liver fat. In the present study, we
evaluated the effects of exercise training on hepatic lipid metabolism
in obese mice. We found that exercise training reduced the SREBP-1c,
FAS and SCD1 protein expression in the liver of obese mice; in addition,
it was observed that exercise training increased ACC phosphorylation
and CPT1 expression in this tissue. In parallel, exercise reduced the
total hepatic lipids and reversed the hepatic steatosis in obese mice.
Physical activity should be strongly promoted for the manage-
ment of fatty liver; however, it is not clear whether exercise beneﬁts
in liver depend on body weight loss. Our results demonstrate that the
exercise training protocol was sufﬁcient to reduce the total body and
epididymal weight in obese mice. In addition, exercise reduced blood
glucose and plasma insulin levels. In this regard, Johnson and col-
leagues provide direct experimental evidence, demonstrating that
regular aerobic exercise reduces hepatic lipids in obesity, even in
the absence of body weight reduction (Johnson et al., 2009). How-
ever, the molecular mechanism by which exercise modulates the
lipid liver metabolism remains unclear. It was demonstrated that
daily physical activity attenuates hepatic steatosis and NAFLD in an
Fig. 1. Protein levels of SREBP-1c, FAS and SCD1. Liver extracts were immunoblotted with anti-SREBP-1c (A), anti-FAS (B), anti-SCD1 (C). Long-run SDS gel electrophoresis of rep-
resentative changes in SREBP-1c precursor (125 kDa) and mature (68 kDa) forms after exercise protocol (A). The membrane was stripped and immunoblotted with anti-β-actin
antibody and used as loaded protein (lower panels in ﬁgures A, B and C). The results of scanning densitometry are expressed as arbitrary units. Bars represent means±S.E.M. of
n=6 mice. #pb0.05, HF versus CT group and *pb0.05, HF+EXE mice versus HF group.
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in part, through enhancement of hepatic fatty acid oxidation and re-
ductions in key protein intermediates of fatty acid synthesis (Rector
et al., 2008a). However, no investigation has been made on
SREBP-1c protein levels in HF mice submitted to physical exercise.
Our study allows concluding that hepatic SREBP-1c, FAS and SCD1
protein levels are signiﬁcantly lower, at the same time that ACC phos-
phorylation increased in obese mice after exercise training. This wasFig. 2. ACC phosphorylation and CPT-1 protein level. Samples were blotted (IB) with (A) anti-
(upper panel) and anti-β-actin for loaded protein (lower panel). The results of scanning den
#pb0.05, HF versus CT and *pb0.05, HF+EXE mice versus HF group.associated with reversion of hepatic steatosis. Conversely, Ikeda and
co-authors showed that swimming and treadmill exercise training in
mice up-regulated expression of lipogenic genes in skeletal muscle,
such as ACC, SCD1, and acyl-CoA diacylglycerolacyltransferase (Ikeda
et al., 2002). These discrepancies between results obtained in studies
using muscle and liver may be due to the well-deﬁned differences in
metabolism between these tissues. Higher lipid content was observed
in the skeletal muscle of endurance trained human subjects, inp-ACC (upper panel) and anti-ACC for total protein level (lower panel) and (B) anti-CPT1
sitometry are expressed as arbitrary units. Bars represent means±S.E.M. of n=6 mice.
Fig. 3. Lipids total content and haematoxylin/eosin staining. Haematoxylin/eosin staining of 5.0-μm sections of livers (n=4) (A). Total hepatic lipids content is expressed as mg/100 g
tissue–1(B). In B, bars represent means±S.E.M. of n=6 mice. #pb0.05, HF versus CT group and *pb0.05, HF+EXE versus HF group.
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addition, several studies reported an increase of SREBP-1c protein levels
in skeletal muscle after exercise training in rodents (Ikeda et al., 2002;
Nadeau et al., 2006). On the other hand, several lines of evidence dem-
onstrate that exercise increases the activity of enzymes involved in lipid
oxidation in the hepatic tissue (Camacho et al., 2006; Takekoshi et al.,
2006). In accordance with these previous studies, our results demon-
strate that exercise increased the ACC phosphorylation and reduced
the SREBP-1c expression in the liver of obese mice.
SREBP-1c is a transcription factor implicated in lipid metabolism
through its regulation of FAS, ACC, and SCD1 (Brown and Goldstein,
1997; Nohturfft et al., 2000, 1999). Our results demonstrated an asso-
ciation between transcription factor SREBP-1c and FAS and SCD1Fig. 4. Representative and quantiﬁcation SREBP-1c expression staining. (A) Signal detectio
merge depict shown positive hepatocytes; 200× ampliﬁcation. Photographs are representat
centage change in SREBP-1c positive cells number of HF) *pb0.05, HF+EXE versus HF grouprotein levels (Fig. 1), ACC phosphorylation (Fig. 2), and total lipids
and histology (Fig. 3) in liver of HF mice and in HF mice submitted
to exercise training. Thus, these data suggest that exercise training re-
duces SREBP-1c protein levels and that this reduction could be re-
sponsible for the modulation of lipogenic enzymes. Interestingly,
exercise training inhibited the membrane-bound (125 kDa) as well
as the nuclear/mature (68 kDa) forms of the protein (Fig. 1A –
long-run SDS-PAGE). These results are important, since they demon-
strate that the decline in the membrane-bound form does not reﬂect
increased cleavage and, thus, no abundance of nuclear SREBP-1c. An
effect on nuclear form could explain the incomplete accordance be-
tween the levels of SREBP-1c measured and the abundance of its tran-
scriptional targets after the exercise protocol.n and image acquisition were performed in ﬂuorescence microscope. White arrows in
ive of six distinct experiments (n=6). (B) Immunohistochemistry quantiﬁcation (per-
p.
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studied. To better clarify its role, some techniques were performed to
achieve direct or indirect inhibition or up-regulation of SREBP-1c,
such as liver-speciﬁc SREBP-1 knockout mice (Yahagi et al., 2002),
mice germline knockouted for SREBP-1a and 1c (Shimano et al., 1997)
and SREBP-1c (Liang et al., 2002), adenovirus-mediated overexpression
(Wang et al., 2010) or recent study performed by our group (Frederico
et al., 2011). In an elegant study, Knebel and colleagues generated mice
with liver-speciﬁc over-expression of mature human SREBP-1c
under control of the albumin promoter and a liver-speciﬁc enhancer
(alb-SREBP-1c) to analyze systemic perturbations caused by this dis-
tinct alteration. SREBP-1c targets speciﬁc genes and causes key enzymes
in lipid metabolism to be upregulated. Thus, the alb-SREBP-1c mice de-
veloped hepatic lipid accumulation featuring a fatty liver by the age of
24 weeks under normocaloric nutrition (Knebel et al., 2012). All these
studies showed that SREBP-1c plays a role in the increased rates of
fatty acid biosynthesis and TG levels in the liver by controlling impor-
tant enzymes of fatty acid synthesis, such as FAS. As shown in Fig. 1, ex-
ercise reduced SREBP-1c and FAS protein levels by similar magnitudes,
suggesting that direct inhibition of transcription factor SREBP-1c is cru-
cial for determination of FAS protein levels; however, the mechanism
by which exercise reduces SREBP-1c and FAS expression remains
unclear and deserves further investigations.
In ratswithNAFLD, suppression of ACCwith a single ASO signiﬁcant-
ly reduces hepatic malonyl-CoA levels in vivo, lower hepatic lipids and
increased hepatic fat oxidation (Savage et al., 2006). In the present
study, we observed higher ACC phosphorylation in the group of animals
submitted to exercise training protocol when compared with the
high-fat feeding groups,which demonstrates lower activity. In addition,
SCD1 protein levels were changed with exercise. In the present study
SCD1 protein level was reduced, possibly because of a reduction in sub-
strate levels, as malonyl-CoA and/or minor transcription by SREBP-1c.
As previously demonstrated, exercise decreases SREBP-1c levels and
for this reason SCD1 alsowas diminished. SCD1-knockoutmice demon-
strated decreased de novo lipogenesis with increased mitochondrial fat
oxidation; these mice were protected from fatty liver (Miyazaki et al.,
2007). In addition, inhibition of SCD1 by ASO in liver and adipose tissue
also showed similar results (Gutiérrez-Juárez et al., 2006).
Conclusions
In summary, we demonstrated that exercise training was effec-
tive to reduce the SREBP-1c, FAS and SCD1 protein expression in
the liver of obese mice; in addition, it was observed that exercise in-
creased ACC phosphorylation and CPT1 protein levels in this tissue;
concomitantly, it was accompanied by the reversion of hepatic
steatosis. Collectively, our data suggest that exercise training could
be an excellent non-pharmacologic treatment to fatty liver diseases.
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